SlideShare a Scribd company logo
I see too many flies……. 
DR.GAYATREE MOHANTY 
SR, DEPT. OF OPHTHALMOLOGY 
KIIMS
HISTORY 
 A 26 year-old male presented on Aug 27th, 2014 
 C/o Sudden Diminution of Vision of Left Eye 
since past 6 days associated with photophobia & 
floaters. 
 No h/o fever, night sweats, wt.loss, loss of appetite, 
rashes, skin ulcers 
 No h/o trauma 
 No exposure to pets 
 No h/o breathlessness or convulsion
ON EXAMINATION 
The right eye had a 
BCVA 6/6 ,normal 
anterior segment & 
normal fundus.
ON EXAMINATION OF THE LEFT EYE 
BCVA: CF close 
Anterior segment: 
 Ciliary congestion, 
 Keratic precipitates : Medium size, 
Homogeneous scattered on corneal 
endothelium. 
 Anterior chamber: Cells +++ Flare + 
 Pupil sluggishly reacting to light 
 Posterior synechiae 
 Pigments on lens
POSTERIOR SEGMENT: 
 Vitreous condensations 
 Grade 2 Vitreous haze. 
Hazy media clouding 
details of optic disc & 
vessels 
 Retinitis: Solitary white 
fluffy lesion near an old 
scar in 
macula overshadowing 
underlying vessels.
ON FFA: 
 Staining of the 
scar 
 Leakage at the site 
of retinitis. 
 No s/o vasculitis
Provisional Diagnosis 
TOXOPLASMA 
RETINOCHOROIDITIS WITH 
SPILL OVER ANTERIOR UVEITIS 
AND VITRITIS.
INVESTIGATIONS
TREATMENT 
 Prednisolone 1mg/kgbdwt/d P.O and tapered 
 Pyrimethamine (50mg/d loading dose, 25mg/d 
maintainance x 4 wks) P.O 
 Sulfadiazine( 2gm loading dose, 1gm qid x 4wks) 
P.O 
 Folic acid 5mg/d 
 Topical Prednisolone acetate 1% e/d 
1hrly 
 Atropine 1% e/d tid
TOXOPLASMOSIS
PATHOGENESIS 
 Toxoplasma gondii 
 Obligate intracellular protozoa 
 Definite host: Cat 
 Infectious agent: Sporozoites 
 Intermediate host: Human 
 Proliferative form: Tachyzoites 
 Mode of Transmission: 
1.Undercooked meat, 
2.Contamination with cat litter 
3.Transplacental transfer
PATHOGENESIS 
 Acute systemic toxoplasmosis in 
immunocompetent patient induce immune 
response (T-cell response) Flu like illness. 
 If reaches retina Tachyzoites convert into 
Bradyzoites and when immunity 
suppressed the Cyst ruptures
CLINICAL FEATURES 
1. Congenital Toxoplasmosis 
2. Acquired Toxoplasmosis 
3. Toxoplasma 
Retinochoroiditis
CONGENITAL TOXOPLASMOSIS 
 Transmitted transplacentally 
 Severity of disease depends on time of 
maternal infestation 
 1st Trimester:15% cases. Severe disease 
leading to spontaneous abortion 
 3rd Trimester: 40% cases. Subclinical disease 
leading to Congenital toxoplasmosis
CONGENITAL TOXOPLASMOSIS 
 Cerebral calcification 
leading to convulsion 
 Bilateral healed 
chorioretinal scars: 
central vision jeopardized 
 Hydrocephalus 
 Microcephaly 
 Psychomotor retardation 
 Organomegaly 
 Jaundice 
 Rashes and fever
ACQUIRED TOXOPLASMOSIS 
 Subclinical: Most frequent 
 Lymphadenopathic syndrome: 
Rare & Self limiting. 
Cervical lymphadenopathy, fever, malaise 
& pharyngitis 
 Meningoencephalitis: Convulsion & Altered 
consciousness 
 Exanthematous form: Rare
TOXOPLASMA 
RETINOCHOROIDITIS 
 Reactivation of previously encysted cyst 
containing scars 
 Cysts rupture to release several tachyzoites 
into retinal cells and induce inflammation. 
 Common age group: 10-35yrs.
TOXOPLASMA RETINITIS 
 Unilateral sudden diminution of 
vision, photophobia and floaters 
 Spill over granulomatous ant. 
uvietis 
 Vitritis: Headlight in fog 
 Retinitis: Unilateral central 
solitary punched out lesion near 
an old macular scar 
 In immunocompromised: 
Bilateral multiple foci of extensive 
inflamm with no pre-existing scar
COMPLICATIONS 
 Direct involvement of macula 
 Involvement of Optic n. head 
with juxtapapillary lesion 
 Papillitis: Rare 
 Occlusion of major blood 
vessel 
 Choroidal neovascularization 
 Serous detachment 
 Tractional RD: Vitreous 
condensation 
 Macular edema
DIAGNOSIS 
 Clinical diagnosis 
 Serological tests for Toxoplasma 
 Sabin Feldman Test 
 Immunofluorescent test 
 Hemagglutination test 
 Enzyme Linked Immunosorbent 
Assay(ELISA)
DIFFERENTIAL DIAGNOSIS 
Toxocariasis 
Tuberculosis 
Sarcoidosis
TREATMENT 
 Self limiting disease 
 Indications for T/t (American Uveitis 
Society) 
 Lesion involving Macula, Papillomacular 
bundle, Optic n. head or Major blood 
vessel 
 Severe vitritis: Risk of tractional RD 
Immunocompromised
TREATMENT REGIMEN 
 Systemic Prednisolone 1mg/kgbdwt/d 
 Pyrimethamine (50mg/d loading dose, 25mg/d 
maintainance x 4 wks) along with 
 Sulfadiazine( 2gm loading dose, 1gm qid x 4wks) 
 Folinic acid 3-5mg/d 
 Other systemic options: Clindamycin, 
Cotrimoxazole, Azithromycin, Atovaquone 
 Topical Prednisolone Acetate for anterior uveitis 
 Cycloplegic
CONCLUSION 
 Ocular toxoplasmosis is a common cause of 
infectious posterior uveitis. 
 Easily diagnosed clinically and lab. diagnosis 
e.g ELISA for Toxoplasma Ab. 
 Treatment is accompanied by resolution of 
active infection in the majority of cases
THANK YOU

More Related Content

What's hot

Central retinal artery occlusion
Central retinal artery occlusionCentral retinal artery occlusion
Central retinal artery occlusion
SSSIHMS-PG
 
Hypertensive Retinopathy
Hypertensive RetinopathyHypertensive Retinopathy
Hypertensive Retinopathy
Hossein Mirzaie
 

What's hot (20)

Ocular toxoplasmosis
Ocular toxoplasmosisOcular toxoplasmosis
Ocular toxoplasmosis
 
Optic neuropathy
Optic neuropathyOptic neuropathy
Optic neuropathy
 
Ocular tb
Ocular tbOcular tb
Ocular tb
 
Ocular toxoplasmosis
Ocular toxoplasmosisOcular toxoplasmosis
Ocular toxoplasmosis
 
ocular Toxoplasmosis
ocular Toxoplasmosisocular Toxoplasmosis
ocular Toxoplasmosis
 
UVEITIS
UVEITISUVEITIS
UVEITIS
 
Proptosis
ProptosisProptosis
Proptosis
 
Normal fundus
Normal fundusNormal fundus
Normal fundus
 
Herpes simplex keratitis & herpes zoster opthalmicus
Herpes simplex keratitis & herpes zoster opthalmicusHerpes simplex keratitis & herpes zoster opthalmicus
Herpes simplex keratitis & herpes zoster opthalmicus
 
Mycotic keratitis
Mycotic keratitisMycotic keratitis
Mycotic keratitis
 
20 ophthalmology clinical cases
20 ophthalmology clinical cases20 ophthalmology clinical cases
20 ophthalmology clinical cases
 
Central retinal artery occlusion
Central retinal artery occlusionCentral retinal artery occlusion
Central retinal artery occlusion
 
Ocular parasitic infection
Ocular parasitic infectionOcular parasitic infection
Ocular parasitic infection
 
Infectious uveitis
Infectious uveitisInfectious uveitis
Infectious uveitis
 
Ocular manifestations of systemic diseases
Ocular manifestations of systemic diseasesOcular manifestations of systemic diseases
Ocular manifestations of systemic diseases
 
Hypertensive Retinopathy
Hypertensive RetinopathyHypertensive Retinopathy
Hypertensive Retinopathy
 
Vogt-Koyanagi-Harada (VKH) syndrome
Vogt-Koyanagi-Harada (VKH) syndrome Vogt-Koyanagi-Harada (VKH) syndrome
Vogt-Koyanagi-Harada (VKH) syndrome
 
Intermeddiate & posterior uveitis dr.k.srikanth, 23.03.2016 revised
Intermeddiate & posterior uveitis  dr.k.srikanth, 23.03.2016 revisedIntermeddiate & posterior uveitis  dr.k.srikanth, 23.03.2016 revised
Intermeddiate & posterior uveitis dr.k.srikanth, 23.03.2016 revised
 
Episcleritis and scleritis
Episcleritis and scleritisEpiscleritis and scleritis
Episcleritis and scleritis
 
Fungal lesions of the eye
Fungal lesions of the eyeFungal lesions of the eye
Fungal lesions of the eye
 

Viewers also liked

Laboratory diagnosis of toxoplasmosis
Laboratory diagnosis of toxoplasmosisLaboratory diagnosis of toxoplasmosis
Laboratory diagnosis of toxoplasmosis
Abhijit Chaudhury
 
Toxoplasmosis
ToxoplasmosisToxoplasmosis
Toxoplasmosis
Ara Ara
 
TOXOPLASMOSIS CONGENITA
TOXOPLASMOSIS CONGENITATOXOPLASMOSIS CONGENITA
TOXOPLASMOSIS CONGENITA
marysabel100
 

Viewers also liked (20)

Toxoplasma
ToxoplasmaToxoplasma
Toxoplasma
 
Toxoplasmosis
ToxoplasmosisToxoplasmosis
Toxoplasmosis
 
Toxoplasmosis
ToxoplasmosisToxoplasmosis
Toxoplasmosis
 
Toxoplasmosis
ToxoplasmosisToxoplasmosis
Toxoplasmosis
 
Toxoplasma
ToxoplasmaToxoplasma
Toxoplasma
 
Laboratory diagnosis of toxoplasmosis
Laboratory diagnosis of toxoplasmosisLaboratory diagnosis of toxoplasmosis
Laboratory diagnosis of toxoplasmosis
 
Toxoplasmosis
ToxoplasmosisToxoplasmosis
Toxoplasmosis
 
Toxoplasmosis
ToxoplasmosisToxoplasmosis
Toxoplasmosis
 
TOXOPLASMOSIS & ASPERGILLOSIS
TOXOPLASMOSIS & ASPERGILLOSISTOXOPLASMOSIS & ASPERGILLOSIS
TOXOPLASMOSIS & ASPERGILLOSIS
 
Toxoplasosis
ToxoplasosisToxoplasosis
Toxoplasosis
 
HIV OCULAR
HIV OCULARHIV OCULAR
HIV OCULAR
 
Molecular Mechanism Of Parasitism
Molecular Mechanism Of ParasitismMolecular Mechanism Of Parasitism
Molecular Mechanism Of Parasitism
 
Toxoplasmosis
ToxoplasmosisToxoplasmosis
Toxoplasmosis
 
Toxoplasmosis
Toxoplasmosis Toxoplasmosis
Toxoplasmosis
 
Toxoplasmosis Epidemiology
Toxoplasmosis EpidemiologyToxoplasmosis Epidemiology
Toxoplasmosis Epidemiology
 
Dry eyes
Dry eyesDry eyes
Dry eyes
 
Toxoplasma
ToxoplasmaToxoplasma
Toxoplasma
 
Hydrops 2014 gphc
Hydrops 2014 gphcHydrops 2014 gphc
Hydrops 2014 gphc
 
TOXOPLASMOSIS CONGENITA
TOXOPLASMOSIS CONGENITATOXOPLASMOSIS CONGENITA
TOXOPLASMOSIS CONGENITA
 
TORCH
TORCHTORCH
TORCH
 

Similar to Toxoplasma

Ocular toxoplasmosis.pptx
Ocular toxoplasmosis.pptxOcular toxoplasmosis.pptx
Ocular toxoplasmosis.pptx
Indrani Sirivella
 
Ed&cornea lecture fatima
Ed&cornea lecture fatimaEd&cornea lecture fatima
Ed&cornea lecture fatima
specialclass
 
pterygiumanditsmanagement-130115081420-phpapp02.pdf
pterygiumanditsmanagement-130115081420-phpapp02.pdfpterygiumanditsmanagement-130115081420-phpapp02.pdf
pterygiumanditsmanagement-130115081420-phpapp02.pdf
ugonnanwoke
 
Clinicopathologic Case Studies
Clinicopathologic Case StudiesClinicopathologic Case Studies
Clinicopathologic Case Studies
narayannaik
 

Similar to Toxoplasma (20)

Dermatologic Emergencies - Dr. Siciliano
Dermatologic Emergencies - Dr. SicilianoDermatologic Emergencies - Dr. Siciliano
Dermatologic Emergencies - Dr. Siciliano
 
Ocular toxoplasmosis.pptx
Ocular toxoplasmosis.pptxOcular toxoplasmosis.pptx
Ocular toxoplasmosis.pptx
 
Protozoal uveitis- toxoplasmosis
Protozoal uveitis- toxoplasmosisProtozoal uveitis- toxoplasmosis
Protozoal uveitis- toxoplasmosis
 
Metastatis endophthalmitis
Metastatis endophthalmitisMetastatis endophthalmitis
Metastatis endophthalmitis
 
Choroiditis
ChoroiditisChoroiditis
Choroiditis
 
Retinal Vasculitis
Retinal VasculitisRetinal Vasculitis
Retinal Vasculitis
 
MUMPS
MUMPS MUMPS
MUMPS
 
Diseases caused by worms and parasites
Diseases caused by worms and parasitesDiseases caused by worms and parasites
Diseases caused by worms and parasites
 
Ed&cornea lecture fatima
Ed&cornea lecture fatimaEd&cornea lecture fatima
Ed&cornea lecture fatima
 
Frsh
FrshFrsh
Frsh
 
pterygiumanditsmanagement-130115081420-phpapp02.pdf
pterygiumanditsmanagement-130115081420-phpapp02.pdfpterygiumanditsmanagement-130115081420-phpapp02.pdf
pterygiumanditsmanagement-130115081420-phpapp02.pdf
 
white_dot_syndromes.pdf
white_dot_syndromes.pdfwhite_dot_syndromes.pdf
white_dot_syndromes.pdf
 
Uveitic glaucoma
Uveitic glaucomaUveitic glaucoma
Uveitic glaucoma
 
Uveitis part 3
Uveitis part 3Uveitis part 3
Uveitis part 3
 
Herpes viruses
Herpes viruses Herpes viruses
Herpes viruses
 
100 mc qsintropicalmedicine
100 mc qsintropicalmedicine100 mc qsintropicalmedicine
100 mc qsintropicalmedicine
 
Febrile neutropenia in chidren
Febrile neutropenia in chidrenFebrile neutropenia in chidren
Febrile neutropenia in chidren
 
Bacterial infection
Bacterial infectionBacterial infection
Bacterial infection
 
Clinicopathologic Case Studies
Clinicopathologic Case StudiesClinicopathologic Case Studies
Clinicopathologic Case Studies
 
Trachoma
TrachomaTrachoma
Trachoma
 

Recently uploaded

Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
MedicoseAcademics
 

Recently uploaded (20)

Aptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyAptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal Testimony
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
รายการตํารับยาแผนไทยแห่งชาติ ฉบับ พ.ศ. 2564.pdf
รายการตํารับยาแผนไทยแห่งชาติ ฉบับ พ.ศ. 2564.pdfรายการตํารับยาแผนไทยแห่งชาติ ฉบับ พ.ศ. 2564.pdf
รายการตํารับยาแผนไทยแห่งชาติ ฉบับ พ.ศ. 2564.pdf
 
World Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptWorld Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 ppt
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
MRI Artifacts and Their Remedies/Corrections.pptx
MRI Artifacts and Their Remedies/Corrections.pptxMRI Artifacts and Their Remedies/Corrections.pptx
MRI Artifacts and Their Remedies/Corrections.pptx
 
End Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feelEnd Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feel
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac Pumping
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
 
NCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDF
NCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDFNCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDF
NCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDF
 
Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.
 
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON  .pptxDIGITAL RADIOGRAPHY-SABBU KHATOON  .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
Retinal consideration in cataract surgery
Retinal consideration in cataract surgeryRetinal consideration in cataract surgery
Retinal consideration in cataract surgery
 

Toxoplasma

  • 1. I see too many flies……. DR.GAYATREE MOHANTY SR, DEPT. OF OPHTHALMOLOGY KIIMS
  • 2. HISTORY  A 26 year-old male presented on Aug 27th, 2014  C/o Sudden Diminution of Vision of Left Eye since past 6 days associated with photophobia & floaters.  No h/o fever, night sweats, wt.loss, loss of appetite, rashes, skin ulcers  No h/o trauma  No exposure to pets  No h/o breathlessness or convulsion
  • 3. ON EXAMINATION The right eye had a BCVA 6/6 ,normal anterior segment & normal fundus.
  • 4. ON EXAMINATION OF THE LEFT EYE BCVA: CF close Anterior segment:  Ciliary congestion,  Keratic precipitates : Medium size, Homogeneous scattered on corneal endothelium.  Anterior chamber: Cells +++ Flare +  Pupil sluggishly reacting to light  Posterior synechiae  Pigments on lens
  • 5. POSTERIOR SEGMENT:  Vitreous condensations  Grade 2 Vitreous haze. Hazy media clouding details of optic disc & vessels  Retinitis: Solitary white fluffy lesion near an old scar in macula overshadowing underlying vessels.
  • 6. ON FFA:  Staining of the scar  Leakage at the site of retinitis.  No s/o vasculitis
  • 7. Provisional Diagnosis TOXOPLASMA RETINOCHOROIDITIS WITH SPILL OVER ANTERIOR UVEITIS AND VITRITIS.
  • 9. TREATMENT  Prednisolone 1mg/kgbdwt/d P.O and tapered  Pyrimethamine (50mg/d loading dose, 25mg/d maintainance x 4 wks) P.O  Sulfadiazine( 2gm loading dose, 1gm qid x 4wks) P.O  Folic acid 5mg/d  Topical Prednisolone acetate 1% e/d 1hrly  Atropine 1% e/d tid
  • 11. PATHOGENESIS  Toxoplasma gondii  Obligate intracellular protozoa  Definite host: Cat  Infectious agent: Sporozoites  Intermediate host: Human  Proliferative form: Tachyzoites  Mode of Transmission: 1.Undercooked meat, 2.Contamination with cat litter 3.Transplacental transfer
  • 12. PATHOGENESIS  Acute systemic toxoplasmosis in immunocompetent patient induce immune response (T-cell response) Flu like illness.  If reaches retina Tachyzoites convert into Bradyzoites and when immunity suppressed the Cyst ruptures
  • 13. CLINICAL FEATURES 1. Congenital Toxoplasmosis 2. Acquired Toxoplasmosis 3. Toxoplasma Retinochoroiditis
  • 14. CONGENITAL TOXOPLASMOSIS  Transmitted transplacentally  Severity of disease depends on time of maternal infestation  1st Trimester:15% cases. Severe disease leading to spontaneous abortion  3rd Trimester: 40% cases. Subclinical disease leading to Congenital toxoplasmosis
  • 15. CONGENITAL TOXOPLASMOSIS  Cerebral calcification leading to convulsion  Bilateral healed chorioretinal scars: central vision jeopardized  Hydrocephalus  Microcephaly  Psychomotor retardation  Organomegaly  Jaundice  Rashes and fever
  • 16. ACQUIRED TOXOPLASMOSIS  Subclinical: Most frequent  Lymphadenopathic syndrome: Rare & Self limiting. Cervical lymphadenopathy, fever, malaise & pharyngitis  Meningoencephalitis: Convulsion & Altered consciousness  Exanthematous form: Rare
  • 17. TOXOPLASMA RETINOCHOROIDITIS  Reactivation of previously encysted cyst containing scars  Cysts rupture to release several tachyzoites into retinal cells and induce inflammation.  Common age group: 10-35yrs.
  • 18. TOXOPLASMA RETINITIS  Unilateral sudden diminution of vision, photophobia and floaters  Spill over granulomatous ant. uvietis  Vitritis: Headlight in fog  Retinitis: Unilateral central solitary punched out lesion near an old macular scar  In immunocompromised: Bilateral multiple foci of extensive inflamm with no pre-existing scar
  • 19. COMPLICATIONS  Direct involvement of macula  Involvement of Optic n. head with juxtapapillary lesion  Papillitis: Rare  Occlusion of major blood vessel  Choroidal neovascularization  Serous detachment  Tractional RD: Vitreous condensation  Macular edema
  • 20. DIAGNOSIS  Clinical diagnosis  Serological tests for Toxoplasma  Sabin Feldman Test  Immunofluorescent test  Hemagglutination test  Enzyme Linked Immunosorbent Assay(ELISA)
  • 21. DIFFERENTIAL DIAGNOSIS Toxocariasis Tuberculosis Sarcoidosis
  • 22. TREATMENT  Self limiting disease  Indications for T/t (American Uveitis Society)  Lesion involving Macula, Papillomacular bundle, Optic n. head or Major blood vessel  Severe vitritis: Risk of tractional RD Immunocompromised
  • 23. TREATMENT REGIMEN  Systemic Prednisolone 1mg/kgbdwt/d  Pyrimethamine (50mg/d loading dose, 25mg/d maintainance x 4 wks) along with  Sulfadiazine( 2gm loading dose, 1gm qid x 4wks)  Folinic acid 3-5mg/d  Other systemic options: Clindamycin, Cotrimoxazole, Azithromycin, Atovaquone  Topical Prednisolone Acetate for anterior uveitis  Cycloplegic
  • 24. CONCLUSION  Ocular toxoplasmosis is a common cause of infectious posterior uveitis.  Easily diagnosed clinically and lab. diagnosis e.g ELISA for Toxoplasma Ab.  Treatment is accompanied by resolution of active infection in the majority of cases